Basic Information
ViRexx Medical Corp. develops therapeutic products for the treatment of chronic viral infections and cancer. The company develops therapeutic products based on three technology platforms, including Chimigen, Targeted Autologous Cancer Thrombosis (T-ACT), and Antibody-Based Immunotherapy (AIT).